Wellstar International, Inc.: No NVOCC operations, focused on medical imaging technology

Wellstar International, Inc. (WLSI) is a development-stage company headquartered in Ohio, United States. The company does not operate as a Non-Vessel Operating Common Carrier (NVOCC) and has no involvement in maritime logistics or containerized shipping. Its primary business activity has been through its subsidiary, Trillennium Medical Imaging, Inc., which focuses on developing and licensing advanced thermal imaging technology for healthcare applications. Wellstar International has not reported any significant operations, revenue, or shipment activity related to maritime or freight forwarding sectors. The company’s technology is used for diagnostic screening in healthcare, including early breast cancer detection and other medical imaging applications. There is no evidence of any logistics, shipping, or container management services being offered by Wellstar International. All available information points to a focus on healthcare technology rather than transportation or supply chain management. Wellstar International’s financial reports indicate no revenue and substantial net losses, with no mention of shipping, container, or NVOCC-related activities. The company’s market capitalization is extremely low, and it is not covered by any major analysts for logistics or shipping industry performance.
The company is led by John Antonio, who serves as Chairman, CEO, and President. Other key executives include Kenneth B. McCoppen (Senior VP & Director) and McKinley Boston (Director). The management team also includes members of a Medical Advisory Board, such as Courtney H. Lyder and Leonard Makowka. There is no evidence of a logistics or maritime operations team.
Wellstar International’s equipment and technology are centered around thermal imaging systems for healthcare diagnostics. The company does not own or operate shipping containers, vessels, or any logistics technology relevant to NVOCC operations. Its technological assets are limited to medical imaging devices and related intellectual property.
Wellstar International does not maintain a global logistics or shipping network. Its operations are limited to the healthcare sector, with some placement of imaging devices in US hospitals and clinics. There is no presence in maritime trade routes, international ports, or freight forwarding markets.
Wellstar International has reported no revenue in recent years and has posted significant net losses. The company’s financial position is weak, with a market capitalization under $10,000 and no evidence of growth or market activity in the shipping or logistics sector. There are no financial indicators of NVOCC operations or related business segments.
Wellstar International, Inc. does not offer any NVOCC, freight forwarding, or maritime logistics services. Its service portfolio is exclusively focused on the development and licensing of thermal imaging technology for medical diagnostics. There are no offerings related to Full Container Load (FCL), Less-than-Container Load (LCL), consolidation, or any shipping-related services. The company’s activities are confined to the healthcare technology sector, with no involvement in containerized cargo or international trade logistics.